TP53BP1 and systemic lupus erythematosus: Studies have shown that increased expression of p202 inhibits AIM2, thus mediating the pathogenicity of IFN in SLE (101); murine studies have also confirmed that p202 inhibits the activation of the AIM2 inflammasome (102, 103).